Danaher Life Sciences, Dx Revenues Rise 58 Percent in Q4

During a conference call, Danaher's CEO said that AB Sciex, which the company purchased a year ago, had a double-digit revenue increase during the second half of 2010.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.